期刊文献+

钌(Ⅱ)杂环醛苯甲酰腙配合物的合成、表征及生物活性 被引量:2

Synthesis,Characterization and Biological Activities of Ru(Ⅱ)-DMSO Complexes with Heterocyclic Hydrazones Ligands
下载PDF
导出
摘要 以cis-[Ru(Ⅱ)Cl2(DMSO)4]和杂环醛苯甲酰腙为原料,合成2个[Ru(Ⅱ)Cl2(DMSO)2L1,2]型(L1为4-吡啶甲醛苯甲酰腙,L2为2-呋喃甲醛苯甲酰腙)配合物。通过元素分析、红外光谱、紫外光谱和核磁共振氢谱对配合物结构进行了表征,利用循环伏安法研究了配合物的电化学性质,并用打孔琼脂扩散法检测了配合物的抑菌效果。用MTT法测试了配合物对人肺癌细胞株A549的抑制活性,IC50值为195.79 mg/L。 Two [ Ru ( Ⅱ ) C12 ( DMSO)2L1,2 ] type complexes were synthesized by mixing precursor complex cis-[ RuC12 (DMSO)4 ] and heterocyclic aldehyde benzoyl hydrazone in ethanol( L~ is pyridine- 4-formaldehyde benzoylhydrazone, L2 is furan-2-carboxaldehyde benzoylydrazone). The new complexes were characterized by means of elemental analysis, IR spectra, UV-Vis spectra and ~HNMR. The electrochemical behavior of the complexes was studied with the help of cyclic voltammetry. The antibacterial activity of the complexes was detected by agar diffusion method. And the anticancer activity of ther complexes was detected by MTI" method. The results indicate that the concentration of IC50 is 195.79 mg/L.
出处 《精细化工》 EI CAS CSCD 北大核心 2014年第3期358-361,共4页 Fine Chemicals
基金 陕西省教育厅自然科学专项研究计划(09JK769)~~
关键词 钌配合物 电化学性质 抑菌活性 生物活性 医药与日化原料 ruthenium complex electrochemical property antibacterial biological activity drug and cosmetic materials
  • 相关文献

参考文献16

  • 1Rabik C A,Dolan M E. Molecular mechanisms of resistance and toxicity associated with platinating agents[J].Cancer Treatment Reviews,2007.9-23.
  • 2牟永平,吴刚,周立社,和彦苓.抗肿瘤金属配合物药物及其药理作用的研究进展[J].中国药理学通报,2007,23(11):1409-1413. 被引量:13
  • 3王晓勇,郭子建.金属抗癌药物设计的新策略和新趋势[J].化学进展,2009,21(5):845-855. 被引量:17
  • 4林晓雯,张艳华.铂类抗肿瘤药的进展与临床评价[J].中国医院用药评价与分析,2011,11(1):4-7. 被引量:39
  • 5Bergamo A,Sava G. Ruthenium complexes can target determinants of tumour malignancy[J].Dalton Transactions,2007,(13):1267-1272.
  • 6Sarah J D,Peter J S. The design of organometallic ruthenium arene anticancer agents[J].CHIMIA,2007,(11):704-715.
  • 7Michael A J,Markus G,Vladimir B A. Antitumour metal compounds:more than theme and variations[J].Dalton Transactions,2008,(02):183-194.
  • 8Levina A,Mitra A,Lay A P. Recent developments in ruthenium anticancer drugs[J].Metallomics,2009.458-470.
  • 9Simon P. Ruthenium compounds as anticancer agents[J].Education in Chemistry,2012,(01):26-29.
  • 10Mahalingam V,Chitrapriya N,Fronczek F R. New Ru (Ⅱ)-dmso complexes with heterocyclic hydrazone ligands towards cancer chemotherapy[J].POLYHEDRON,2008.1917-1924.

二级参考文献143

  • 1刘杰,计亮年,梅文杰.金属钌配合物的抗肿瘤活性及其作用机理[J].化学进展,2004,16(6):969-974. 被引量:24
  • 2Kiehyka R, Fakhoury J, Moitessier N, et al. Chem. Eur. J., 2008, 14:1145--1154.
  • 3Kieltyka R, Englebienne P, Fakhoury J, et al. J. Am. Chem. Soe., 2008, 130:10040--10041.
  • 4Pennington .l D, Jacobs K M, Sun L, et al. Curr. Pharm. Design, 2007, 13:3368--3377.
  • 5Urig S, Fritz-Wolf K, Reau R, et al. Angew. Chem. Int. Ed., 2006, 45:1881--1886.
  • 6Barnard P J, Bemers-Pdee S J. Coord. Chem. Rev., 2007, 251: 1889--1902.
  • 7Wang Y, He Q Y, Che C M, et al. Proteomics, 2006, 6:131--142.
  • 8Ott I, Schmidt K, Kircher B, et al. J. Med. Chem., 2005, 48 : 622--629.
  • 9Failes TW, CuUinane C, Diakos C I, et al. Chem. Eur. J., 2007, 13 : 2974--2982.
  • 10Timerbaev A R, Hartinger C G, Aleksenko S S, et al. Chem. Rev., 2006, 106:2224--2248.

共引文献66

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部